Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.

Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, McGarry K, Seidman JG, Seidman CE.

J Clin Invest. 2002 Feb;109(3):357-62.

2.

Accuracy of echocardiographic estimates of left ventricular mass in mice.

Collins KA, Korcarz CE, Shroff SG, Bednarz JE, Fentzke RC, Lin H, Leiden JM, Lang RM.

Am J Physiol Heart Circ Physiol. 2001 May;280(5):H1954-62.

3.

Metabolic cardiomyopathies.

Guertl B, Noehammer C, Hoefler G.

Int J Exp Pathol. 2000 Dec;81(6):349-72. Review.

4.

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.

Seidman JG, Seidman C.

Cell. 2001 Feb 23;104(4):557-67. Review. No abstract available.

5.

Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.

Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, Smoot L, Mullen MP, Woolf PK, Wigle ED, Seidman JG, Seidman CE.

N Engl J Med. 2000 Dec 7;343(23):1688-96.

6.

Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling.

Roth W, Deussing J, Botchkarev VA, Pauly-Evers M, Saftig P, Hafner A, Schmidt P, Schmahl W, Scherer J, Anton-Lamprecht I, Von Figura K, Paus R, Peters C.

FASEB J. 2000 Oct;14(13):2075-86.

PMID:
11023992
7.

Matrix metalloproteinases: not-so-innocent bystanders in heart failure.

Lee RT, Libby P.

J Clin Invest. 2000 Oct;106(7):827-8. No abstract available.

8.

Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.

Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muhonen L, Bowles NE, Towbin JA.

J Clin Invest. 2000 Sep;106(5):655-62.

9.

Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).

Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, Sue CM, Yamamoto A, Murakami N, Shanske S, Byrne E, Bonilla E, Nonaka I, DiMauro S, Hirano M.

Nature. 2000 Aug 24;406(6798):906-10.

PMID:
10972294
10.

Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice.

Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lüllmann-Rauch R, Janssen PM, Blanz J, von Figura K, Saftig P.

Nature. 2000 Aug 24;406(6798):902-6.

PMID:
10972293
11.

Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells.

Kirschke H, Eerola R, Hopsu-Havu VK, Brömme D, Vuorio E.

Eur J Cancer. 2000 Apr;36(6):787-95.

PMID:
10762753
12.

Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy.

Li H, Wang J, Wilhelmsson H, Hansson A, Thoren P, Duffy J, Rustin P, Larsson NG.

Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3467-72.

13.

Secreted cathepsin L generates endostatin from collagen XVIII.

Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W.

EMBO J. 2000 Mar 15;19(6):1187-94.

14.

Lysosomal cysteine proteases: more than scavengers.

Turk B, Turk D, Turk V.

Biochim Biophys Acta. 2000 Mar 7;1477(1-2):98-111. Review.

PMID:
10708852
15.

Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement.

Brodsky GL, Muntoni F, Miocic S, Sinagra G, Sewry C, Mestroni L.

Circulation. 2000 Feb 8;101(5):473-6.

16.

Proteases involved in MHC class II antigen presentation.

Villadangos JA, Bryant RA, Deussing J, Driessen C, Lennon-Duménil AM, Riese RJ, Roth W, Saftig P, Shi GP, Chapman HA, Peters C, Ploegh HL.

Immunol Rev. 1999 Dec;172:109-20. Review.

PMID:
10631941
17.

MEROPS: the peptidase database.

Rawlings ND, Barrett AJ.

Nucleic Acids Res. 2000 Jan 1;28(1):323-5.

18.

Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice.

Emanueli C, Maestri R, Corradi D, Marchione R, Minasi A, Tozzi MG, Salis MB, Straino S, Capogrossi MC, Olivetti G, Madeddu P.

Circulation. 1999 Dec 7;100(23):2359-65.

19.

Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.

Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal D, Hrstka RF, Williamson R, Campbell KP.

Cell. 1999 Aug 20;98(4):465-74.

20.

Nonischemic heart failure: epidemiology, pathophysiology, and progression of disease.

Follath F.

J Cardiovasc Pharmacol. 1999 Jun;33 Suppl 3:S31-5. Review.

PMID:
10442682

Supplemental Content

Support Center